DOLLARS AT WORK
Dollars at Work
The Rexall OneWalk to Conquer Cancer (formerly known as The Weekend to Women’s Cancers) has made an enormous impact on the work of the Princess Margaret Cancer Centre, as highlighted below. As we walk in the Rexall OneWalk to Conquer Cancer, the funds we raise will support world- leading research, new clinical and technological innovations, and the continuation of the important patient Survivorship program.
- $54.7 million to The Campbell Family Institute for Breast Cancer Research led by Tak Mak, with 7 Principal Investigators 3 Affiliate Scientists, 1 Emeritus Scientist, and 112 staff.
- Tak Mak and his team of researchers from The Campbell Family Research Institute announced a new “sharpshooter” cancer drug that will target an enzyme called PLK4, which plays a crucial role in the process of cancer cell division. On July 18, 2013 Dr. Mak and his team gained clearance by Health Canada to proceed with the drug into Phase I Clinical Trial in Canada.*
- Scientists led by Drs. Mona Gauthier and Tak Mak have discovered how BRCA1 gene mutations specifically predispose women to breast and ovarian
- Pamela Ohashi’s research into T-cell activation and boosting the immune system to fight tumors. Her work focuses on understanding the signaling pathways of T-cells to help activate, direct and enhance anti-tumor responses in cancer. Clinical trial of her team’s adoptive cell therapy began in the Fall of 2013. Dr. Pamela Ohashi’s research into T-cell activation and immunotherapy to fight breast tumours, is part of The Campbell Family Institute funding.
- $8.7 million to purchase cutting edge research equipment and support breast cancer research activities in the PMH research expansion at MaRS (Medical and Related Science), including immunotherapy and stem cell biology.
- $3 million to create The Weekend to End Breast Cancer Chair in Breast Cancer Research, held by Dr. Tak Mak, a world renowned cancer research scientist.
- $1.5 million to the Walker Innovation Program, which supports researchers and new ideas that have the potential for advancing scientific knowledge of breast
- $2.1 million to support Dr. Norman Boyd’s research into breast cancer prevention, focusing on the understanding of mammographic density as a risk factor.
- $1.8 million to support Mass Spectrometer program
- $500,000 to support research at The Campbell Family Cancer Research Institute for equipment, lab expenses, research and staff related expenses and research operations.
- $3.9 million toward a comprehensive breast imaging program and the purchase of a breast MRI and digital mammography
- $3 million toward a newly revamped and re-designed Lau Breast Centre that provides complete care for breast cancer patients.
- $2.9 million to support clinical trials for breast cancer and $500,000 for fellowship program
- $2 million to support an extensive Tumour Bank, database maintenance and pathology
- $1.3 million to support Dr. David McCready’s rapid diagnosis pilot study, which is now The Gattuso Rapid Diagnostic Centre and sees up to 1,500 patients a
- $550,000 to support the clinical trial of intraoperative radiation therapy, led by David McCready and Dr. Anthony Fyles.
- $250,000 toward the design and creation of the new Conway Chemotherapy and Transfusion Centre, the largest centre of its kind in North Am
- $1.2 million to support the surgical robotics program for gynecologic cancer patients.
- $160,000 toward the Familial Ovarian Cancer Clinic, which now also provides genetic counselling for breast cancer
- $6.6 million for other clinical enhancements and other research programs
- $2.5 million to support Princess Margaret’s Space Transformation which is a multi-phase project that will create a transformative environment for Personalized Cancer
- $130,000 towards grant matching program
- $11.8 million for the establishment and continued support of the first in-hospital Survivorship Clinic and Program in Canada. This includes ELLICSR, a 12,000-square-foot innovative research centre, and caringvoices.ca, an award-winning online community for survivors and their
- $1 million to provide reconstructive breast surgery for women who have had breast cancer.
*New cancer drug development is a long and risk-filled process. We are very encouraged by this discovery and reaching this major milestone. The drug discovery from Dr. Tak Mak and Dr. Dennis Slamon announced by The Princess Margaret Cancer Foundation in June 2013 has been cleared by Health Canada and the University Health Network Research Ethics Board, and is in clinical trials. For more information please visit www.canadiancancertrials.ca.